This category is being discussed as part of a Categories for discussion process. As a result of this discussion, pages and files in this category may be recategorized (not deleted).
Treatment for children with high-risk neuroblastoma with anti-disialoganglioside mAb ch14.18, IL-2, and GM-CSF plus 13-cis-retinoic acid after myeloablative chemotherapy improves survival, but 40 % of patients still relapse during or after…